Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05922514 · ClinicalTrials.gov registry record
A Clinical Registry of Spontaneous Intracranial Hypotension
A clinical trial of Spontaneous Intracranial Hypotension, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05922514: Recruiting study of Spontaneous Intracranial Hypotension, sponsored by Mayo Clinic.
NCT05922514 is a study of Spontaneous Intracranial Hypotension that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05922514, a study of Spontaneous Intracranial Hypotension, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design of future clinical trials of this technique.
Primary Outcome
HIT-6 is a 6-item validated headache assessment tool designed to provide a global measure of headache impact in social functioning, role functioning, vitality, cognition, psychological distress, and severity of headache. Total score ranges 36-78: 36-49: little or no impact; 50-55 some impact; 56-59 substantial impact; \>60 severe impact.
Conditions Studied
Interventions
- PROCEDURE Transvenous Embolization of Cerebrospinal Fluid-Venous Fistula
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-18 |
| Est. Completion | 2026-07 |
What NCT05922514 shows while recruiting
NCT05922514 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Spontaneous Intracranial Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Transvenous Embolization of Cerebrospinal Fluid-Venous Fistula is the first listed.
NCT05922514 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05922514 about?
NCT05922514 is a clinical study titled "A Clinical Registry of Spontaneous Intracranial Hypotension". The purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design of future clinical tr...
What is the current status of trial NCT05922514?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-06-18. Estimated completion is 2026-07.
What conditions does trial NCT05922514 study?
This clinical trial studies the following conditions: Spontaneous Intracranial Hypotension.
What interventions are being tested in trial NCT05922514?
The interventions under investigation include: Transvenous Embolization of Cerebrospinal Fluid-Venous Fistula (PROCEDURE).
Who is sponsoring clinical trial NCT05922514?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05922514 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI